NSE filing, NSE: ABREL. Summary written from the filing by ALFA Finder's alert engine.
Aditya Birla Real Estate Ltd: key numbers
- Share price
- ₹1,053.80
- Market cap
- ₹11,770 Cr
- Revenue (annual)
- ₹407.2 Cr
- Net profit (annual)
- ₹-103.2 Cr
- P/E (TTM)
- 15.5×Sector 33.7×
- Promoter holding
- 50.21%+0.00% QoQ
- FII holding
- 8.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aditya Birla Real Estate Ltd
All →Aditya Birla Real Estate Earnings Call Transcript: Key Takeaways
Strong H1 revenue and collection growth driven by project deliveries, though Niara Tower C delay impacts immediate pre-sales trajectory.
Aditya Birla Real Estate Investor Presentation: Key Takeaways
Q2 FY27 RE net total income ₹268 Cr (+755% YoY), continuing EBITDA ₹195 Cr, collections ₹752 Cr (+47%). Net debt cut to ₹284 Cr; shift toward cash monetisation.
Aditya Birla Real Estate Management Change
Aditya Birla Real Estate's board approved appointing Ms. Jayati Bansal as Independent Director. The five-year term starts 6 December 2026, subject to shareholder approval.
Aditya Birla Real Estate Q2 FY27 Results: Turns Profitable, Net Profit ₹918.7 Cr
Aditya Birla Real Estate Ltd reported revenue from operations of ₹825 Cr (+743.6% YoY) and net profit of ₹918.7 Cr for Q2 FY27.
- Key figure
- Net profit ₹918.7 Cr
Aditya Birla Real Estate Capacity Expansion
Birla Estates, a subsidiary of Aditya Birla Real Estate, announced a new Hinjewadi residential project with ₹1,650 Crore revenue potential. The 1.25 million sq. ft. development expands the company's Pune portfolio.
- saleable residential area
- 1.25 million sq. ft.
Aditya Birla Real Estate Annual General Meeting
Aditya Birla Real Estate Limited issued a notice of postal ballot to seek shareholder approval for the 'ABREL ESOP Scheme 2026' and related trust activities.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.